Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities research analysts at HC Wainwright cut their FY2027 earnings estimates for shares of Ardelyx in a note issued to investors on Friday, August 7th. HC Wainwright analyst M. Caufield now expects that the biopharmaceutical company will earn $0.35 per share for the year, down from their previous […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | What is KeyCorp’s Estimate for Arcadis FY2027 Earnings? | 0 | 13.04 | 10-08-2026 |
| 2 | HC Wainwright Issues Pessimistic Estimate for ARWR Earnings | 0 | 13.33 | 10-08-2026 |
| 3 | FY2029 Earnings Estimate for AMLX Issued By HC Wainwright | 0 | 11.9 | 10-08-2026 |
| 4 | HC Wainwright Issues Pessimistic Forecast for OESX Earnings | 0 | 12.58 | 10-08-2026 |
| 5 | HC Wainwright Weighs in on Nuvation Bio Q1 Earnings | 0 | 9.79 | 10-08-2026 |
| 6 | HC Wainwright Has Weak Forecast for Cytosorbents Q1 Earnings | 0 | 11.13 | 10-08-2026 |
| 7 | Zacks Research Analysts Increase Earnings Estimates for ARWR | 0 | 11.84 | 10-08-2026 |
| 8 | HC Wainwright Weighs in on Delcath Systems Q1 Earnings | 0 | 10.45 | 10-08-2026 |
| 9 | Equities Analysts Set Expectations for XENE Q1 Earnings | 0 | 11.84 | 10-08-2026 |
| 10 | FY2027 EPS Estimate for Astrazeneca Decreased by Analyst | 0 | 13.83 | 10-08-2026 |